Encumbrance created on 57.49% shares via offshore loan facility
COHANCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.5 pts less than Nifty Smallcap 250 and 2.3 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
CSC Global Capital Markets, acting as agent for lenders (Barclays, Deutsche Bank, BNP Paribas, MUFG, Standard Chartered), disclosed creation of encumbrance over 21.99 crore shares (57.49%) of Cohance Lifesciences. Promoter entities Berhyanda (33.34%) and Jusmiral Holdings (24.15%) availed term loans under a Facility Agreement dated June 11, 2026, effective June 16, 2026. The pledge is indirect, via 100% shares of the Borrowers pledged by their shareholders, with restrictions on disposal of the Cohance shares.
Majority promoter stake now encumbered via offshore loan covenants. Restricts share disposal and signals leverage taken by promoters. Monitor for default risk.